UBS Group’s Relmada Therapeutics RLMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $120K | Sell |
|
|||||
|
2025
Q2 | $108K | Buy |
|
|||||
|
2025
Q1 | $39.1K | Sell |
|
|||||
|
2024
Q4 | $112K | Buy |
|
|||||
|
2024
Q3 | $409K | Sell |
|
|||||
|
2024
Q2 | $386K | Sell |
|
|||||
|
2024
Q1 | $601K | Buy |
|
|||||
|
2023
Q4 | $521K | Buy |
|
|||||
|
2023
Q3 | $377K | Buy |
|
|||||
|
2023
Q2 | $244K | Buy |
|
|||||
|
2023
Q1 | $3.57K | Sell |
|
|||||
|
2022
Q4 | $20.6K | Sell |
|
|||||
|
2022
Q3 | $225K | Buy |
|
|||||
|
2022
Q2 | $25K | Hold |
|
|||||
|
2022
Q1 | $36K | Sell |
|
|||||
|
2021
Q4 | $72K | Sell |
|
|||||
|
2021
Q3 | $124K | Buy |
|
|||||
|
2021
Q2 | $148K | Sell |
|
|||||
|
2021
Q1 | $230K | Sell |
|
|||||
|
2020
Q4 | $238K | Buy |
|
|||||
|
2020
Q3 | $211K | Sell |
|
|||||
|
2020
Q2 | $374K | Buy |
|
|||||
|
2020
Q1 | $104K | Sell |
|
|||||
|
2019
Q4 | $166K | Buy |
|